Name: UMIN ID:
Unique ID issued by UMIN | UMIN000030603 |
---|---|
Receipt number | R000034950 |
Scientific Title | Phase II trial of docetaxel plus ramucirumab combination therapy in patients with advanced EGFR gene mutation positive advanced stage non-squamous cell nonsmall cell lung cancer (HSR 1701) |
Date of disclosure of the study information | 2018/01/04 |
Last modified on | 2022/12/22 14:12:15 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/12/28 00:31:42 | ||
2 | Update | 2019/06/21 21:13:33 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Institutions |
|
3 | Update | 2022/12/22 14:12:15 | Recruitment status Date of IRB Last follow-up date |